INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

80,757 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Grant or award
A—
44.8K sh
Mar 3, 2026Mar 5, 2026
Page 1439 of 2019
← PrevNext →
traded Mar 3, 2026
+2d
SEC Form 4

Evidence

17
SJ
Shen Zheng JohnDirector
VICRVICOR CORP
Option exercise
M—
1,217 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

17
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A—
50.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
HM
Hafner Patrick MEVP, Pres Outback Steakhouse
BLMNBloomin' Brands, Inc.
Option exercise
M—
8,101 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
FJ
Fink William JosephEVP & Chief Lending Officer
PFSPROVIDENT FINANCIAL SERVICES INC
Grant or award
A—
4,085 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
15.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

17
SA
Scanlon Thomas ACorporate Controller & PAO
CWTCALIFORNIA WATER SERVICE GROUP
Grant or award
A—
1,650 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Grant or award
A—
40.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
BJ
Boone Travis JDirector, PRESIDENT & CEO
ORNOrion Group Holdings Inc
Grant or award
A—
241.6K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
PM
Prosor MayaChief Business Officer
LMNDLemonade, Inc.
Open-market sale
SELL$11K
223 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
2,109 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
55.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

17
HC
Hornstein CarolynSVP, Controller & CAO
INGMIngram Micro Holding Corp
Grant or award
A—
8,407 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

17
VM
Vicente MonicaSVP, Chief Financial Officer
FDPDEL MONTE CORP
Option exercise
M—
179 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
CB
Coll Crespo BlasCHIEF MEDICAL OFFICER
GPCRStructure Therapeutics Inc.
Tax withholding
F$248K
11.8K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
GC
Glessner ColeenEVP, Quality & Ethics, and CPL
EBSEmergent BioSolutions Inc.
Tax withholding
F$69K
8,199 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

16
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$1.37M
33.9K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
OS
O'Neill ShivGC AND CORP SEC
ELANElanco Animal Health Inc
Tax withholding
F$118K
4,738 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
MY
Ma YingliCHIEF TECHNOLOGY OFFICER
GPCRStructure Therapeutics Inc.
Tax withholding
F$237K
11.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
SS
Sanfrey Jeffrey ScottChief Operating Officer
BLBDBlue Bird Corp
Option exercise
M$64K
5,192 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

16
PJ
Perl JessicaSVP, General Counsel, Corp Sec
EBSEmergent BioSolutions Inc.
Tax withholding
F$55K
6,465 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

16
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Tax withholding
F$79K
9,397 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

16
HW
Hartzel WilliamSVP, Bioservices
EBSEmergent BioSolutions Inc.
Tax withholding
F$80K
9,493 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

16
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$1.30M
29.3K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

16
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$1.17M
27.1K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

16
MM
Moylan MishaSee Remarks
HLTHilton Worldwide Holdings Inc.
Tax withholding
F$62K
204 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Tax withholding
F$86K
2,682 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

16
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Tax withholding
F$90K
10.6K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

15
YJ
Yoon JunCHIEF FINANCIAL OFFICER
GPCRStructure Therapeutics Inc.
Tax withholding
F$468K
22.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

15
SM
Stienstra MichaelGM & Chief Insurance, HHIP
HIPOHippo Holdings Inc.
Grant or award
A—
9,874 sh
Mar 2, 2026Mar 5, 2026
traded Mar 2, 2026
+3dSEC Form 4

Evidence

15
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$286K
10.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

15
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Tax withholding
F$411K
14.6K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

15
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$284K
10.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

15
LB
Landry BenjaminGeneral Counsel
HCATHealth Catalyst, Inc.
Tax withholding
F$35K
20.8K sh
Mar 2, 2026Mar 5, 2026
traded Mar 2, 2026
+3dSEC Form 4

Evidence

15
OT
Ostergaard TorbenCEO Spinnaker
HIPOHippo Holdings Inc.
Grant or award
A—
9,874 sh
Mar 2, 2026Mar 5, 2026
traded Mar 2, 2026
+3dSEC Form 4

Evidence

15
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$8,243
4,966 sh
Mar 2, 2026Mar 5, 2026
traded Mar 2, 2026
+3dSEC Form 4

Evidence

14
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Grant or award
A—
15.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

14
SA
Steenberge Michael AnthonyChief Accounting Officer
PARPAR TECHNOLOGY CORP
Open-market sale · 10b5-1 plan
SELL$41K
2,342 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

13
DS
Daoust StephanChief Operating Officer
TASKTaskUs, Inc.
Grant or award
A—
8,730 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

13
BJ
Boone Travis JDirector, PRESIDENT & CEO
ORNOrion Group Holdings Inc
Grant or award
A—
73.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence